|
| Scientific Program |
| |
|
| Scientific Program | Search Abstract |
| |
|
|
| Session |
| |
| Chronic myeloid leukemia - Clinical |
| Date: |
Saturday, 06 June 2009
|
| Time: | 18:00-19:15 |
| Room: | |
| |
| 18:00-19:15 |
|
THERAPY WITH IMATINIB IN ELDERLY CML PATIENTS (=65 YEARS) IS WELL TOLERATED BUT CYTOGENETIC AND MOLECULAR REMISSIONS SEEM TO BE ACHIEVED LATER COMPARED TO YOUNGER PATIENTS
| 0625 |
| Pletsch, Nadine,
Lauseker, M.,
Saussele, S.,
Leitner, A.,
Jung-Munkwitz, S.,
Müller, M.C.,
Haferlach, C.,
Schlegelberger, B.,
Ehninger, G.,
Fischer, T.,
Hossfeld, D.K.,
Kolb, H.J.,
Krause, S.W.,
Nerl, C.,
Pralle, H.,
Gratwohl, A.,
Tobler, A.,
Heimpel, H.,
Balleisen, L.,
Einsele, H.,
Ho, A.D.,
Falge, C.,
Hänel, M.,
Pfreundschuh, M.,
Kanz, L.,
Stegelmann, F.,
Köhne, C.,
Kremers, S.,
Spiekermann, K.,
Berdel, W.,
Waller, C.F.,
Bentz, M.,
Pfirrmann, M.,
Hochhaus, A.,
Hehlmann, R.,
Hasford, J.
(Mannheim, Germany) |
| |
| 18:00-19:15 |
|
SOKAL SCORE AND RESPONSE TO IMATINIB IN EARLY CHRONIC PHASE CML: THE GIMEMA CML WORKING PARTY EXPERIENCE ON 559 PATIENTS
| 0626 |
| Baccarani, Michele,
Rosti, Gianantonio,
Castagnetti, Fausto,
Palandri, Francesca,
Gugliotta, Gabriele,
Ferrara, Felicetto,
Gozzini, Antonella,
Pulini, Stefano,
Montefusco, Enrico,
Sica, Simona,
Turri, Diamante,
Ferrero, Dario,
Musolino, Caterina,
Bocchia, Monica,
Radaelli, Franca,
Martinelli, Giovanni,
Breccia, Massimo,
Pane, Fabrizio,
Saglio, Giuseppe
(Bologna, Italy) |
| |
| 18:00-19:15 |
|
NILOTINIB IN CHRONIC MYELOID LEUKEMIA PATIENTS IN CHRONIC PHASE (CML-CP) WITH IMATINIB RESISTANCE OR INTOLERANCE: 24-MONTH FOLLOW-UP RESULTS OF A PHASE 2 STUDY
| 0627 |
| Kantarjian, Hagop,
Giles, Francis,
Bhalla, Kapil,
Pinilla, Javier,
Larson, Richard,
Gattermann, Norbert,
Ottmann, Oliver,
Wang, Jim,
Gallagher, Neil,
Baccarani, Michele,
Le Coutre, Philipp
(Houston, United States of America) |
| |
| 18:00-19:15 |
|
SUBOPTIMAL RESPONSE TO IMATINIB 400 MG DAILY FOR CHRONIC MYELOID LEUKEMIA IN EARLY CHRONIC PHASE: A GIMEMA CML WP ANALYSIS OF 423 CONSECUTIVE PATIENTS
| 0628 |
| Castagnetti, Fausto,
Gugliotta, Gabriele,
Breccia, Massimo,
Sartor, Donatella,
Cavazzini, Francesco,
Rupoli, Serena,
Pregno, Patrizia,
Bruno, Martino,
Palandri, Francesca,
Amabile, Marilina,
Testoni, Nicoletta,
Marzocchi, Giulia,
Poerio, Angela,
Iacobucci, Ilaria,
Martinelli, Giovanni,
Saglio, Giuseppe,
Pane, Fabrizio,
Baccarani, Michele,
Rosti, Gianantonio
(Bologna, Italy) |
| |
| 18:00-19:15 |
|
THE ORALLY ACTIVE AURORA KINASE A INHIBITOR MLN8237 HAS POTENT ACTIVITY IN PRECLINICAL MODELS OF RESISTANT CHRONIC MYELOID LEUKEMIA AND SIGNIFICANTLY INCREASES THE EFFICACY OF NILOTINIB
| 0629 |
| Kelly, Kevin,
Swords, Ronan,
Nawrocki, Steffan,
Mahalingam, Devalingam,
Medina, Ernest,
Smith, Sabrina,
Padmanabhan, Swaminathan,
Ecsedy, Jeffrey,
Giles, Francis J.,
Carew, Jennifer
(San Antonio, United States of America) |
| |
| 18:00-19:15 |
|
FINAL SAFETY ANALYSIS OF 1,793 CML PATIENTS FROM ENACT (EXPANDING NILOTINIB ACCESS IN CLINICAL TRIALS) STUDY IN ADULT PATIENTS WITH IMATINIB-RESISTANT OR –INTOLERANT CHRONIC MYELOID LEUKEMIA (CML)
| 0630 |
| Nicolini, Franck,
Alimena, Giuliana,
Al-Ali, Haifa-Kathrin,
Turkina, Anna,
Shen, Zhixiang,
Jootar, Saengsuree,
Smith, Graeme,
De Souza, Carmino,
Wang, Jim,
Berton, Myriam,
Szczudlo, Tomek,
Rizzieri , David
(Lyon, France) |
| |
| 18:00-19:15 |
|
NILOTINIB IN CHRONIC MYELOID LEUKEMIA PATIENTS IN ACCELERATED PHASE (CML-AP) WITH IMATINIB RESISTANCE OR INTOLERANCE: 24-MONTH FOLLOW-UP RESULTS OF A PHASE 2 STUDY
| 0631 |
| Hochhaus, Andreas,
Giles, Francis,
Apperely, Jane,
Ossenkoppele, Gert,
Wang, Jim,
Gallagher, Neil,
Baccarani, Michele,
Cortes, Jorge,
Kantarjian, Hagop,
Le Coutre, Philipp
(Mannheim, Germany) |
| |
| 18:00-19:15 |
|
AGE HAS NO IMPACT ON OUTCOME OF EARLY CHRONIC PHASE, PH-POS CML, IMATINIB TREATED PATIENTS: A NATIONWIDE ANALYSIS ON 559 CASES OF THE GIMEMA CML WP
| 0632 |
| Gugliotta, Gabriele,
Castagnetti, Fausto,
Amabile, Marilina,
Testoni, Nicoletta,
Palandri, Francesca,
Iacobucci, Ilaria,
Soverini, Simona,
Luatti, Simona,
Breccia, Massimo,
Specchia, Giorgina,
Intermesoli, Tamara,
Radaelli, Franca,
Abruzzese, Elisabetta,
Usala, Emilio,
Saglio, Giuseppe,
Martinelli, Giovanni,
Pane, Fabrizio,
Baccarani, Michele,
Rosti, Gianantonio
(Bologna, Italy) |
| |
| 18:00-19:15 |
|
EXPANDING NILOTINIB ACCESS IN CLINICAL TRIALS (ENACT) STUDY IN ADULT PATIENTS (PTS) WITH IMATINIB-RESISTANT OR –INTOLERANT CHRONIC MYELOID LEUKEMIA (CML): SUBGROUP ANALYSIS OF PATIENTS WHO FAILED PRIOR DASATINIB THERAPY
| 0633 |
| Nicolini, Franck,
Alimena, Giuliana,
Al-Ali, Haifa-Kathrin,
Turkina, Anna,
Shen, Zhixiang,
Jootar, Saengsuree,
Smith, Graeme,
Conchon, Monika,
Wang, Jim,
Berton, Myriam,
Szczudlo, Tomek,
Rizzieri , David
(Lyon, France) |
| |
| 18:00-19:15 |
|
RELEASE OF INTRACELLULAR CALCIUM PRIMES CHRONIC MYELOID LEUKAEMIA CELLS FOR TYROSINE KINASE INHIBITOR (TKI)-INDUCED APOPTOSIS
| 0634 |
| Forchap, Sylvia,
Pirmohamed, Munir,
Clark, Richard
(Liverpool, United Kingdom) |
| |
| 18:00-19:15 |
|
A SHORT (12M) IFNA/IMATINIB COMBINED THERAPY CAN SECURE LONG TERM MAINTENANCE OF IMATINIB INDUCED CYTOGENETIC REMISSION AFTER DISCONTINUATION OF IMATINIB IN CML PATIENTS WITHOUT MOLECULAR REMISSION
| 0635 |
| Hardan, Izhar,
Stemmer, SM,
Amariglio, N,
Koren-Michowitz , M,
Levi , I,
Shimoni, A,
Binenbaum, Y,
Ben-Yehuda , D,
Bennett, M,
Rechavi, G,
Nagler, A
(Tel-Hashomer, Israel) |
| |
| 18:00-19:15 |
|
RESPONSE TO NILOTINIB IS SIMILAR IN IMATINIB-RESISTANT CHRONIC MYELOID LEUKEMIA PATIENTS IN ACCELERATED PHASE (CML-AP) WITH AND WITHOUT BCR-ABL MUTATIONS EXCEPT E255K/V, Y253H, AND F359C/V
| 0636 |
| Martinelli, Giovanni,
Kim, Dong-Wook,
Saglio, Giuseppe,
Branford, Susan,
Erben, Philip,
Gottardi, Enrico,
Beppu, Lan,
Haque, Ariful,
Shou, Yaping,
Woodman, Richard,
Soverini, Simona,
Kantarjian, Hagop,
Hughes, Tim,
Hochhaus, Andreas,
Radich, Jerald
(Bologna, Italy) |
| |
| 18:00-19:15 |
|
A STUDY OF PLASMA LEVELS OF IMATINIB AND ITS BIOACTIVE METABOLITE CGP-74588 REVEALS NO CORRELATION WITH SUBSEQUENT CLINICAL OUTCOME IN IMATINIB-TREATED CHRONIC MYELOID LEUKAEMIA
| 0637 |
| Davies, Andrea,
Hayes, Alison,
Giannoudis, Athina,
Lucas, Claire,
Knight, Katy,
Watmough, Sarah,
Pirmohamed, Munir,
Clark, Richard
(Liverpool, United Kingdom) |
| |
| 18:00-19:15 |
|
DASATINIB IN THE TREATMENT OF CHRONIC PHASE CML PATIENTS AGED > 60 YEARS RESISTANT/INTOLERANT TO IMATINIB
| 0638 |
| Latagliata, Roberto,
Breccia, Massimo,
Stagno, Fabio,
Luciano, Luigiana,
Gozzini, Antonella,
Annunziata, Mario,
De Matteis, Silvia,
Albano, Francesco,
Ulisciani, Stefano,
Pregno, Patrizia,
Pacilli, Matteo,
Abruzzese, Elisabetta,
Martino, Bruno,
Tiribelli, Mario,
Russo Rossi, Antonella,
Sica, Simona,
Vitolo, Umberto,
Montefusco, Enrico,
Rege Cambrin, Giovanna,
Ferrara, Felicetto,
Santini, Valeria,
Pane, Fabrizio,
Di Raimondo, Francesco,
Alimena, Giuliana
(Rome, Italy) |
| |
| 18:00-19:15 |
|
EFFICACY OF NILOTINIB AFTER IMATINIB FAILURE IN PH-POSITIVE CHRONIC MYELOID LEUKEMIA: IMPACT OF ADDITIONAL CHROMOSOMAL ABERRATIONS AND FREQUENCY OF BCR-ABL POINT MUTATIONS
| 0639 |
| Kim, Theo,
Türkmen, Seval,
Schwarz, Michaela,
Daniel, Peter,
Dörken, Bernd,
Le Coutre, Philipp
(Berlin, Germany) |
| |
| 18:00-19:15 |
|
THE ONCOGENIC KINASE BCR-ABL DIRECTLY REGULATES SPLICING EVENTS OF BCLX THROUGH A QUATERNARY COMPLEX COORDINATED BY NCK-BETA AND SAM-68 ADAPTER PROTEINS
| 0640 |
| Bracco, Enrico,
Rosso, Valentina,
Mussino , Stefano,
Arruga, Francesca,
Carturan , Sonia,
Messa, Francesca,
Panuzzo, Cristina,
Lo Iacono, Marco,
Nicoli, Paolo,
Messa, Emanuela,
Rotolo , Antonella,
Spagna, Marco,
Morotti, Alessandro M.D.,
Balbo, Alessandra PhD,
Iacobucci I., Ilaria,
Martinelli , Giovanni,
Cilloni, Daniela MD, PhD,
Saglio, Giuseppe MD, PhD
(Orbassano (TO), Italy) |
| |
| 18:00-19:15 |
|
COMPARATIVE IN VITRO CELLULAR DATA ALONE IS INSUFFICIENT TO GUIDE CHOICE OF BCR-ABL INHIBITOR TO TREAT IMATINIB-RESISTANT CHRONIC MYELOID LEUKEMIA (CML)
| 0641 |
| Laneuville, Pierre,
DiLea, Clifford,
Mestan, Jürgen,
Yin, Ophelia,
Manley, Paul
(Quebec, Canada) |
| |
| 18:00-19:15 |
|
DYNAMICS OF CYTOGENETIC AND MOLECULAR RESPONSE TO NILOTINIB IS SIMILAR IN IMATINIB-RESISTANT CHRONIC MYELOID LEUKEMIA PATIENTS IN CHRONIC PHASE (CML-CP) WITH AND WITHOUT BCR-ABL MUTATIONS EXCEPT E255K/V, Y253H, AND F359C/V
| 0642 |
| Saglio, Giuseppe,
Hochhaus, Andreas,
Martinelli, Giovanni,
Gottardi, Enrico,
Soverini, Simona,
Branford, Susan,
Müller, Martin,
Beppu, Lan,
Haque, Ariful,
Shou, Yaping,
Woodman, Richard,
Kantarjian, Hagop,
Radich, Jerald,
Hughes, Tim,
Kim, Dong-Wook
(Orbassano-torino, Italy) |
| |
| 18:00-19:15 |
|
LONG-TERM SURVIVAL OF PATIENTS WITH LATE CHRONIC PHASE PH-POSITIVE CHRONIC MYELOID LEUKEMIA RECEIVING TYROSINE KINASE INHIBITOR THERAPY AFTER INTERFERON FAILURE
| 0643 |
| Turkina, Anna G.,
Stakhina , Olga (P),
Gusarova , Galina,
Zakharova , Elena,
Chelysheva , Ekaterina,
Vinogradova , Olga,
Kolosheinova , TI,
Goryacheva , CR,
Kolosova , LYu,
Domracheva , EV,
Zakharova , AV,
Abakumov , EM,
Kulikov , Sergei,
Khoroshko , ND
(Moscow, Russian Federation) |
| |
| 18:00-19:15 |
|
PREGNANCY AMONG THE PATIENTS WITH CHRONIC MYELOID LEUKEMIA ON IMATINIB THERAPY
| 0644 |
| Chelysheva, Ekaterina,
Turkina, A.G.,
Gusarova, G.A.,
Kolosheinova, T.I.,
Sokolova, M.A.,
Khoroshko, N.D.,
Pepelyaeva, V.M.,
Gavrilova, L.V.
(Moscow, Russian Federation) |
| |
|